國立虎尾科技大學 |

Quantifying Cancer Patient Survival : = Extensions and Applications of Cure Models and Life Expectancy Estimation.

紀錄類型:	書目-語言資料,手稿 : Monograph/item
正題名/作者:	Quantifying Cancer Patient Survival :/
其他題名:	Extensions and Applications of Cure Models and Life Expectancy Estimation.
作者:	Andersson, Therese M-L.
面頁冊數:	1 online resource (67 pages)
附註:	Source: Dissertations Abstracts International, Volume: 83-03, Section: B.
Contained By:	Dissertations Abstracts International83-03B.
標題:	Statistical methods. -
電子資源:	click for full text (PQDT)
ISBN:	9798744408596

Quantifying Cancer Patient Survival : = Extensions and Applications of Cure Models and Life Expectancy Estimation.
Andersson, Therese M-L.

Quantifying Cancer Patient Survival :Extensions and Applications of Cure Models and Life Expectancy Estimation. - 1 online resource (67 pages)

Source: Dissertations Abstracts International, Volume: 83-03, Section: B.

Thesis (Ph.D.)--Karolinska Institutet (Sweden), 2013.

Includes bibliographical references

Cancer patient survival is the single most important measure of cancer patient care. By quantifying cancer patient survival in different ways further insights can be gained in terms of temporal trends and differences in cancer patient survival between groups. The objective of this thesis is to develop and apply methods for estimating the cure proportion and loss in expectation of life for cancer patients.In paper I, a cure model was used to study temporal trends in survival of patients with acute myeloid leukaemia in Sweden. Cancer patient survival was estimated in a relative survival setting and quantified as the proportion cured and the median survival time of uncured for different age groups and by calendar time of diagnosis. We found a dramatic increase in the cure proportion for the age group 19-40, although almost no improvement was seen for patients aged 70-79 at diagnosis.In paper II, a flexible parametric cure model was developed to overcome some limitations with standard parametric cure models. This model is a special case of a non-mixture cure model, using splines instead of a parametric distribution for the modeling. The fit of the flexible parametric cure model was compared to the fit of a Weibull non-mixture cure model, and shown to be superior in cases when the standard non-mixture cure model did not give a good fit or did not converge. Software was developed to enable use of the method.In paper III, the possibility of using a flexible parametric relative survival model for estimating life expectancy and loss in expectation of life was evaluated. Extrapolation of the survival function is generally needed, and the flexible parametric relative survival model was shown to extrapolate the survival very well. The method was evaluated by comparing survival functions extrapolated from 10 years past diagnosis to observed survival by the use of data with 40 years of follow-up. Software was developed to enable use of the method.In paper IV, the life expectancy and loss in expectation of life was estimated for colon cancer patients in Sweden. Even though relative survival was similar across age for colon cancer patients, the loss in expectation of life varied greatly by age, since young patients have more years to lose. We also found that the life expectancy of colon cancer patients improved over time. However, the improvement has to a large extent mimicked the improvement seen in the general population, and therefore there were no large changes in the loss in expectation of life.In conclusion, the methods presented in this thesis are additional tools for estimating and quantifying population-based cancer patient survival, that can lead to an improved understanding of different aspects of the prognosis of cancer patients.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2024

Mode of access: World Wide Web

ISBN: 9798744408596Subjects--Topical Terms:

784334
Statistical methods.
Index Terms--Genre/Form:

554714
Electronic books.

Quantifying Cancer Patient Survival : = Extensions and Applications of Cure Models and Life Expectancy Estimation.
LDR:04157ntm a22003617 4500 001 1149018
005 20240930130028.5
006 m o d
007 cr bn ---uuuuu
008 250605s2013 xx obm 000 0 eng d
020 $a 9798744408596
035 $a (MiAaPQ)AAI28423672
035 $a (MiAaPQ)Karolinska_1061641668
035 $a AAI28423672
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Andersson, Therese M-L. $3 1475132
245 1 0 $a Quantifying Cancer Patient Survival : $b Extensions and Applications of Cure Models and Life Expectancy Estimation.
264 0 $c 2013
300 $a 1 online resource (67 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 83-03, Section: B.
500 $a Includes supplementary digital materials.
500 $a Advisor: Lambert, Paul;Dickman, Paul;Lambe, Mats.
502 $a Thesis (Ph.D.)--Karolinska Institutet (Sweden), 2013.
504 $a Includes bibliographical references
520 $a Cancer patient survival is the single most important measure of cancer patient care. By quantifying cancer patient survival in different ways further insights can be gained in terms of temporal trends and differences in cancer patient survival between groups. The objective of this thesis is to develop and apply methods for estimating the cure proportion and loss in expectation of life for cancer patients.In paper I, a cure model was used to study temporal trends in survival of patients with acute myeloid leukaemia in Sweden. Cancer patient survival was estimated in a relative survival setting and quantified as the proportion cured and the median survival time of uncured for different age groups and by calendar time of diagnosis. We found a dramatic increase in the cure proportion for the age group 19-40, although almost no improvement was seen for patients aged 70-79 at diagnosis.In paper II, a flexible parametric cure model was developed to overcome some limitations with standard parametric cure models. This model is a special case of a non-mixture cure model, using splines instead of a parametric distribution for the modeling. The fit of the flexible parametric cure model was compared to the fit of a Weibull non-mixture cure model, and shown to be superior in cases when the standard non-mixture cure model did not give a good fit or did not converge. Software was developed to enable use of the method.In paper III, the possibility of using a flexible parametric relative survival model for estimating life expectancy and loss in expectation of life was evaluated. Extrapolation of the survival function is generally needed, and the flexible parametric relative survival model was shown to extrapolate the survival very well. The method was evaluated by comparing survival functions extrapolated from 10 years past diagnosis to observed survival by the use of data with 40 years of follow-up. Software was developed to enable use of the method.In paper IV, the life expectancy and loss in expectation of life was estimated for colon cancer patients in Sweden. Even though relative survival was similar across age for colon cancer patients, the loss in expectation of life varied greatly by age, since young patients have more years to lose. We also found that the life expectancy of colon cancer patients improved over time. However, the improvement has to a large extent mimicked the improvement seen in the general population, and therefore there were no large changes in the loss in expectation of life.In conclusion, the methods presented in this thesis are additional tools for estimating and quantifying population-based cancer patient survival, that can lead to an improved understanding of different aspects of the prognosis of cancer patients.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2024
538 $a Mode of access: World Wide Web
650 4 $a Statistical methods. $3 784334
650 4 $a Population. $3 527762
650 4 $a Morphology. $3 1183868
650 4 $a Gerontology. $3 559846
650 4 $a Aging. $3 559847
650 4 $a Breast cancer. $3 1413554
650 4 $a Calendars. $3 1472787
650 4 $a Survival analysis. $3 1413553
650 4 $a Performance evaluation. $3 1246613
650 4 $a Tumors. $3 676261
650 4 $a Skin cancer. $3 1475134
650 4 $a Prostate cancer. $3 1475133
650 4 $a Mortality. $3 654488
650 4 $a Leukemia. $3 788485
650 4 $a Lung cancer. $3 1026751
650 4 $a Life expectancy. $3 679590
650 4 $a Metastasis. $3 673770
650 4 $a Medical prognosis. $3 1471053
650 4 $a Patients. $3 963142
650 4 $a Medical diagnosis. $3 1471052
655 7 $a Electronic books. $2 local $3 554714
690 $a 0493
690 $a 0287
690 $a 0351
710 2 $a Karolinska Institutet (Sweden). $3 1469673
710 2 $a ProQuest Information and Learning Co. $3 1178819
773 0 $t Dissertations Abstracts International $g 83-03B.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28423672 $z click for full text (PQDT)